Ryan Deschner's Stock Ratings

Raymond James Analyst

Ryan Deschner is an analyst at Raymond James. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/12/2025

Overall Average Return

24.0%

Smart Score

75.7%

Overall Average Return Percentile

84th

Number of Ratings

12
Buy NowGet Alert
05/09/2025APLSBuy Now
Apellis Pharmaceuticals
$17.85191.32%
Ryan Deschner75%
$75 → $52DowngradeStrong Buy → OutperformGet Alert
05/09/2025LQDABuy Now
Liquidia
$14.6597.95%
Ryan Deschner75%
$27 → $29MaintainsStrong BuyGet Alert
03/12/2025INZYBuy Now
Inozyme Pharma
$1.15943.48%
Ryan Deschner75%
$24 → $12MaintainsOutperformGet Alert
03/10/2025TRVIBuy Now
Trevi Therapeutics
$6.61338.73%
Ryan Deschner75%
$9 → $29UpgradeOutperform → Strong BuyGet Alert
02/21/2025ARDXBuy Now
Ardelyx
$3.71250.4%
Ryan Deschner75%
$15 → $13ReiteratesStrong Buy → Strong BuyGet Alert
01/14/2025SPRYBuy Now
ARS Pharmaceuticals
$13.55106.64%
Ryan Deschner75%
$26 → $28MaintainsStrong BuyGet Alert
08/30/2024TRVIBuy Now
Trevi Therapeutics
$6.6136.16%
Ryan Deschner75%
→ $9Initiates → OutperformGet Alert
08/19/2024LQDABuy Now
Liquidia
$14.6584.3%
Ryan Deschner75%
$27 → $27UpgradeOutperform → Strong BuyGet Alert
08/16/2024LQDABuy Now
Liquidia
$14.6584.3%
Ryan Deschner75%
→ $27Initiates → OutperformGet Alert
08/13/2024SPRYBuy Now
ARS Pharmaceuticals
$13.5562.36%
Ryan Deschner75%
$18 → $22UpgradeOutperform → Strong BuyGet Alert
07/25/2024SPRYBuy Now
ARS Pharmaceuticals
$13.5532.84%
Ryan Deschner75%
→ $18Initiates → OutperformGet Alert
06/18/2024OMGABuy Now
Omega Therapeutics
Ryan Deschner75%
→ $12Initiates → OutperformGet Alert
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free